Last reviewed · How we verify
Tonsillitis
Approved treatments
- Cefradex · Bristol-Myers Squibb
- Ceclor
- Cefzil · Teva Pharmaceuticals USA
- Cedax · Burke Therap
- Cefadrox
- Vantin
- Dirythromycin
- Suprax
Suprax works by inhibiting the bacterial enzyme 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, disrupting bacterial cell wall synthesis. - Cephradin · Sohag University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Tonsillitis patent landscape — cliff calendar, originator estates, attackable patents
- Tonsillitis treatment landscape brief
- Tonsillitis treatment updates RSS
Frequently asked questions about Tonsillitis
What drugs treat Tonsillitis?
Tracked treatments include Cefradex, Ceclor, Cefzil, Cedax, Cefadrox, Vantin, Dirythromycin, Suprax.
What is the treatment for Tonsillitis?
Standard treatment for Tonsillitis includes Cefradex, Ceclor, Cefzil, Cedax, Cefadrox. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Tonsillitis patent cliff · Tonsillitis CI report
- Treatment: Cefradex · Bristol-Myers Squibb
- Treatment: Ceclor
- Treatment: Cefzil · Teva Pharmaceuticals USA
- Treatment: Cedax · Burke Therap
- Treatment: Cefadrox
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing